Using a continuous glucose monitor to help stick with GLP-1 meds
Part of Hormones & metabolism clinical trials.
This study tests whether using a continuous glucose monitor (CGM) like the FreeStyle Libre 3 helps people with type 2 diabetes stay on their new GLP-1 or GIP/GLP-1 medication longer. You must be starting a GLP-1 or GIP/GLP-1 drug for the first time and not already using a CGM.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes.
- You are about to start taking a GLP-1 or GIP/GLP-1 medication for the first time.
- You are willing to use a continuous glucose monitor (CGM) or continue using your current diabetes device.
- You are willing to have blood drawn to check your HbA1c.
- You are not currently using a continuous glucose monitor (CGM) as part of your routine care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This study tests whether using a continuous glucose monitor (FreeStyle Libre 2) along with smart insulin pens or caps helps people with type 1 diabetes better manage their blood sugar on their own. If you already use this device and take multiple daily insulin injections, you may be eligible.
This study uses a continuous glucose monitor to help people with prediabetes or type 2 diabetes better manage their blood sugar and weight, and will test how well it works in a real-world workplace setting.
This study checks whether patient-guided lifestyle changes, supported by a continuous glucose monitor (a sensor), can improve blood sugar control in adults with type 2 diabetes. It may help you and your care team see how food, activity, and habits affect your readings.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar in people with diabetes and gastroparesis (slow stomach emptying). If you have type 1 or type 2 diabetes and stomach symptoms, this could help doctors better understand your glucose patterns.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.